THE BAKER ADMINISTRATION recently released its budget proposal for one of their most high-profile issues: drug prices in the Medicaid program. To the surprise of many in the biopharmaceutical industry, there are some…
The midterms are over and it’s time to get back to discussing issues that impact Americans on a daily basis. Things like health care and, specifically how to reduce costs.…
If you’re suffering from a rare, debilitating disease like MS, or cystic fibrosis, or some forms of cancer, and you need a boutique biologic to save your life, Dr. Steve…
There’s a little-known group out there that just made several disappointing recommendations for all those living with prostate cancer. Sadly, it could mean the difference between life or death for…
We should resist dangerous effort to limit health care coverage WHEN A PERSON is first diagnosed with epilepsy their world is turned upside down. The questions come fast and furious.…
Hope is a powerful elixir. My family was dealt an unexpected blow nearly 26 years ago when our son Gunnar was diagnosed with cystic fibrosis, a debilitating genetic disease for…
By Terry Wilcox In the debate over prescription drug prices, one group is being overlooked: people with rare diseases. The needs of these patients, who rely on specialty medications for their…
Is a person with a chronic illness less valuable than a healthy person? I realize this is an uncomfortable question, but as our elected officials and policy makers address the…
Hope is a powerful elixir. My family was dealt an unexpected blow nearly 26 years ago when our son Gunnar was diagnosed with cystic fibrosis, a debilitating genetic disease for…
The Institute for Clinical and Economic Review (ICER) is emerging as a major player in the health care cost debate. The organization through its affiliates is holding public meetings focusing…